Notice NOT-HG-20-005 from the NIH Guide for Grants and Contracts

Notice NOT-AG-20-003 from the NIH Guide for Grants and Contracts

Negotiable: SRG: Computational Biologist Location: Stevenage Length: 12 months Salary: CompetitiveSRG are a strategic recruitment partner to a global pharmaceutical co Stevenage, England

Negotiable: SRG: Computational Biologist Location: Stevenage Length: 12 months Salary: Competitive SRG are a strategic recruitment partner to a global pharmaceutical c Stevenage, England

Competitive Salary: EMBL: Ensembl Web Back-end Project Leader Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: DevOps Engineer Location: EMBL-E Cambridge, Cambridgeshire, England

Negotiable: Paramount Recruitment: Senior Rare Disease Analyst/ Statistical Geneticist London Genomics England have a very interesting and challenging role available for a Senior Rar London, England

Notice NOT-OH-20-002 from the NIH Guide for Grants and Contracts

Notice NOT-OH-20-001 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-010 from the NIH Guide for Grants and Contracts

Notice NOT-HG-19-025 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-021 from the NIH Guide for Grants and Contracts. (Reissue of PAR-16-458) The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with outstanding mentors. Candidates are eligible to apply for support from this program from ~12 months prior to the start of the proposed postdoctoral position to within 12 months after starting in postdoctoral position. Based on the early timeframe of eligibility, and the discouragement of inclusion of preliminary data, this NINDS F32 seeks to foster early, goal-directed planning and to encourage applications for bold and/or innovative projects by the candidate that have the potential for significant impact. Applications are expected to incorporate strong training in quantitative reasoning and the quantitative principles of experimental design and analysis. Support by this program is limited to the first 3 years of a candidate's activity in a specific laboratory or research environment, so as to further encourage early fellowship application and timely completion of mentored training of the postdoctoral candidate in a single environment.

Notice NOT-RM-20-001 from the NIH Guide for Grants and Contracts

Notice NOT-AG-20-002 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-394 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide dissertation awards in all areas of research within NIAs strategic priorities to increase the diversity of the scientific research workforce engaged in research on aging and aging-related health conditions.

Funding Opportunity PAR-20-030 from the NIH Guide for Grants and Contracts. The goal of this -program is to support locally relevant research in critical areas of HIV-associated non-communicable diseases (NCDs) at Low- and Middle-Income Country (LMIC) Institutions, to enhance research capacity and build a network of researchers both within and across LMICs to address this critical burden. This initiative is expected to stimulate new research on the interplay between HIV and development of NCDs in persons living with HIV (PLWH), including exploratory studies to uncover the extent to which HIV infection influences the etiopathogenesis of the NCDs; and to identify and develop appropriate approaches for effective diagnosis, prevention, therapeutic interventions and integrated clinical care for PLWH with the comorbid conditions. Applicants should develop their studies in keeping with the NIH HIV/AIDS Research Priorities ( https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html ). Research teams should contain an appropriate mix of expertise to accomplish the proposed studies, including partnerships between HIV and NCD researchers who can initiate new ideas and determine feasibility of novel approaches to understand and reduce the long-term suffering from the comorbid disorders. Applicants will also be asked to address the needs of collaborating LMIC institutions to develop capacity for carrying out research in this field. U.S. and LMIC investigators are eligible to apply for collaborative projects to be done at LMIC sites; however, a U.S. investigator must apply together with an LMIC investigator. LMICs are defined by the World Bank classification system according to Gross National Income (GNI) per capita as low-income, lower-middle-income, and upper-middle-income (http://data.worldbank.org/about/country-classifications/country-and-lending-groups

Funding Opportunity PAR-20-034 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage projects to generate fundamental knowledge of affective processes. Basic affective science projects should have key consequences for single (e.g., cancer screening) and multiple (e.g., adherence to oral chemotherapy regimen) event decisions and behaviors across the cancer prevention and control continuum. The FOA is expected to encourage collaboration among cancer control researchers and those from scientific disciplines not traditionally connected to cancer control applications (e.g., affective and cognitive neuroscience, decision science, consumer science) to elucidate perplexing and understudied problems in affective and decision sciences with downstream implications for cancer prevention and control.

Competitive Salary: EMBL: Software Engineer Location: EMBL Cambridge, Cambridgeshire, England

Funding Opportunity PAR-20-035 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is supported by Collaborative Research on Addiction (CRAN) at the National Institutes of Health (NIH), a trans-NIH partnership composed of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and the National Cancer Institute (NCI). The intent of this FOA is two-fold: (1) characterize how the neurobiological alterations, associated behaviors, and public health consequences arising from polysubstance use differ from, or are similar to, those observed in single drug use; (2) promote integrative polysubstance research along a translational pipeline, consisting of basic science research in animals, human-based laboratory investigations, and epidemiological studies. These dual objectives will be accomplished with an Exploratory/Developmental Phased Award (R61/R33) mechanism, where polysubstance research can occur in any of these translational stages during the R61 phase and these findings will be rapidly back- or forward-integrated into another stage during the R33 phase, permitting accelerated bi-directional research exchange.

Notice NOT-DK-20-005 from the NIH Guide for Grants and Contracts